
1001 - 5000 employees
Founded 2003
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative medicines that address serious unmet medical needs. With a strong commitment to research and development, Jazz focuses on creating life-changing therapies, emphasizing the importance of collaboration, diversity, and employee engagement in its operations. The company prides itself on transforming patients' lives through its meaningful product offerings and a culture that fosters enthusiasm and flexibility.
🔥 17 hours ago
🔔 Pennsylvania – Remote
💵 $212k - $318k / year
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
👻 Ghost score 0%
Where this job comes from
Posted on Jazz Pharmaceuticals's careers page, not through a job board
First seen by Remote Rocketship 17 hours ago
Still open on Jazz Pharmaceuticals's site. Checked 1 hour ago.

1001 - 5000 employees
Founded 2003
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative medicines that address serious unmet medical needs. With a strong commitment to research and development, Jazz focuses on creating life-changing therapies, emphasizing the importance of collaboration, diversity, and employee engagement in its operations. The company prides itself on transforming patients' lives through its meaningful product offerings and a culture that fosters enthusiasm and flexibility.
• Lead global and US payer evidence strategy across marketed assets in Jazz’s neurology portfolio • Maximize brand potential, defend value, secure expanded access, and drive post-launch evidence generation • Develop evidence strategies for label expansions, new formulations, line extensions, and expanded patient subpopulations • Partner with Medical Affairs, Clinical Development, and Biostatistics on Phase 3b/4, pragmatic, and expanded access studies • Lead rare disease registries, natural history extensions, and post-authorization safety/efficacy studies • Design comparative effectiveness, adherence, burden-of-illness, and real-world data studies • Co-create HTA reassessment strategies and analytical packages with EU/INT HEOR teams • Direct updates to Global Value Dossiers, systematic literature reviews, and meta-analyses • Lead AMCP dossiers, unbranded value summaries, and state Medicaid submission dossiers • Design and train teams on interactive economic models and reactive scientific presentations • Ensure US HEOR materials comply with FDAMA Section 114, the 21st Century Cures Act, and FDA HCEI guidance • Evaluate outcomes-based risk-sharing agreements and real-world endpoint tracking frameworks • Monitor US health policy, ICER, and value framework developments • Formulate and execute cost-effectiveness, cost-utility, budget impact, and cost-offset modeling strategies • Build and adapt economic models using mature clinical and real-world data • Serve as GVHEOR representative in IEGP governance and align evidence initiatives with brand objectives • Partner with Market Access and cross-functional teams on post-launch evidence initiatives • Lead publications, manuscripts, and conference presentations • Manage budgets, external HEOR consultancies, academic partners, and CROs • Provide mentorship and technical guidance to evidence and value generation staff
• Master’s degree (MSc, MS, MPH) or PhD in Health Economics, Outcomes Research, Pharmacoeconomics, or a closely related quantitative field • Minimum of 7–10 years of experience in HEOR, Global Value, or Health Economics within the biopharmaceutical industry or a top-tier HEOR consulting firm • Extensive experience designing and executing post-marketing HEOR strategies, real-world comparative effectiveness studies, and evidence roadmaps supporting label expansions, line extensions, and value defense • Comprehensive knowledge of the US managed care landscape and global HTA environments • Proven technical expertise building, adapting, and validating economic models, including Markov, partitioned survival, microsimulation, and dynamic budget impact models • Proven track record collaborating with US Market Access, Pricing/Contracting, and Payer Field Teams to develop compliant customer-facing tools, interactive budget models, and AMCP dossiers • Demonstrated understanding of rare disease post-launch evidence challenges • Working knowledge of major US and global healthcare databases and advanced epidemiological methods • Demonstrated ability to work with regional HEOR teams, especially EU/INT • Ability to balance evidence strategy with hands-on execution of complex technical deliverables • Exceptional verbal, written, and presentation skills; ability to influence cross-functional teams and defend methodologies • Experience with neurology assets preferred • Track record leading HEOR strategy and evidence deliverables for marketed pharmaceutical products • Launch lead for at least 2 assets as US HEOR lead, or country-level HTA lead • Experience conducting post-marketing RWE, patient registry studies, and economic evaluations • Strong peer-reviewed publication record in health economics and outcomes research
• Discretionary annual cash bonus or incentive compensation • Discretionary equity grants • Medical insurance • Dental insurance • Vision insurance • 401k retirement savings plan • Flexible paid vacation
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🔥 18 hours ago
Director leading construction and commissioning of industrial wastewater treatment plants for Probst Group. Managing teams, budgets, contractors, safety, schedules, and project delivery.
🔥 18 hours ago
Regional Medical Affairs Director leading six MSLs for Tarsus Pharmaceuticals, an eyecare-focused biopharmaceutical company. Driving scientific engagement, KOL relationships, medical strategy, and field execution.
🔥 18 hours ago
Regional fundraising director growing donor relationships and philanthropic revenue for Texas Tribune journalism and The Waco Bridge. Managing Dallas–Fort Worth and Waco portfolios across Texas.
🔥 19 hours ago
Assurance M&A integration director leading diligence and integration of acquired accounting practices at Citrin Cooperman. Coordinating teams, systems, staffing, training, and change management.
🔥 19 hours ago
Material Strategy Director advancing recycling, EPR, and sustainable materials strategies for Circular Action Alliance. Coordinating state programs, end-market partnerships, compliance, and data-driven implementation.